CHRU de Lille Hopital Calmette

Lille 59037

0 studies enrolling now · 2 studies all time

What they study most

HER2-mutant Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma

Studies at this site

• Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer — Completed
• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer — Stopped early